Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1127283

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage fairer pricing by pharmaceutical companies for drugs supplied to the NHS.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255651
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The 2019 Voluntary Scheme for Branded Medicines Pricing and Access, and the statutory scheme for branded medicines pricing, work together to control the cost of branded medicines to the National Health Service and ensure it stays within affordable limits.</p><p> </p><p>The 2019 Voluntary Scheme began on 1 January 2019 and will run for five years until the end of 2023. The Voluntary Scheme aims to provide stability and predictability for all parties in terms of the United Kingdom’s branded medicines expenditure and the medicines pricing and access environment for the period 2019 to 2023. It also aims to achieve a balance between patient access, affordability and supporting the development of innovative new medicines, including support for small companies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:30:06 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127290

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 May 2019 to Question 249855 on Blood: Contamination, whether any treatment is offered to donors whose blood donation tests are positive for infection.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	255657
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>NHS Blood and Transplant’s Clinical Support Team provides support and advice for any donor whose blood donation tests positive for infection.</p><p>The donor will be asked to discuss the result with one of NHS Blood and Transplant’s Clinical Support Team clinical staff and, with the donor’s consent, NHS Blood and Transplant’s Clinical Support Team will arrange a referral to their general practitioner or a specialist, who will discuss the need for any treatment with the donor.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:55:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	478 label Biography information for Lord Field of Birkenhead

1127292

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availability of (a) Evorel and (b) Femseven sequi patches.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	255686
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The manufacturer of Evorel transdermal patches has confirmed that supplies of all presentations are currently available. However, they have stated that in some cases supplies are slightly lower than normal and therefore they are applying restrictions on orders as a precaution to ensure limited stock is maintained.</p><p>The Department is aware that the supplier of FemSeven Sequi patches is experiencing long term supply issues. As a result, they are expected to be out of stock until late 2019. We remain in regular contact with the company to resolve this as soon as possible.</p><p>Supplies of other hormone replacement therapy transdermal patches continue to remain available and patients affected have been advised to discuss these alternative treatment options with their clinician.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/05/2019 14:48:55 answering member 4455 label Biography information for Seema Kennedy
tabling member	4418 label Biography information for Justin Madders

1127293

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that advance decisions on mental health treatment are respected and adhered to.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	255683
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>Last year Professor Sir Simon Wessely, president of the Royal Society of Medicine, submitted his independent review of the Mental Health Act. The review made 154 recommendations – including the establishment of new statutory advance choice documents, so that people’s wishes and preferences carry far more legal weight.</p><p>We have accepted this recommendation.</p><p>The Government is currently considering the detailed recommendations of the review and will respond in due course. We remain committed to reforming mental health law and will develop and bring forward legislation when Parliamentary time allows.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 255684 question first answered 24/05/2019 12:35:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4368 label Biography information for Neil Coyle

1127294

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure the adequate (a) monitoring and (b) use of advance decisions in mental health care.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	255684
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>Last year Professor Sir Simon Wessely, president of the Royal Society of Medicine, submitted his independent review of the Mental Health Act. The review made 154 recommendations – including the establishment of new statutory advance choice documents, so that people’s wishes and preferences carry far more legal weight.</p><p>We have accepted this recommendation.</p><p>The Government is currently considering the detailed recommendations of the review and will respond in due course. We remain committed to reforming mental health law and will develop and bring forward legislation when Parliamentary time allows.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 255683 question first answered 24/05/2019 12:35:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4368 label Biography information for Neil Coyle

1127316

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Crimes of Violence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2019 to Question 252108 on Crimes of Violence, whether his Department has plans to make an estimate of the cost to the NHS of violent crime.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	255688
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Department currently has no plans to make an estimate of the cost to the National Health Service of violent crime.</p><p>However, the report ‘The economic and social costs of crime’<em>,</em> published by the Home Office, includes information on the costs associated with physical and emotional harms as a consequence of crime for health services. The report is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-economic-and-social-costs-of-crime" target="_blank">https://www.gov.uk/government/publications/the-economic-and-social-costs-of-crime</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:36:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft

1127317

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of young people developing bowel cancer.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255652
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Obesity and poor diet are risk factors for bowel cancer in young people.</p><p>The second chapter of the world-leading childhood obesity plan was published in June 2018. This builds on the real progress made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:24:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127319

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Self-harm and Suicide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2019 to Question 252092 on Self-Harm and Suicide, where data on (a) self-harm and (b) suicide among family members of victims of violence is held.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	255689
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>This data is not available. The fact that a person who self harms or takes their own life is a family member of a victim of violence is not routinely recorded by the National Health Service.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:58:26 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft

1127327

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diffuse Intrinsic Pontine Glioma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of access to NHS support for sufferers of diffuse intrinsic pontine glioma.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	255692
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>No specific assessment has been made by the Department at this time.</p><p>Care for children with Diffuse Intrinsic Pontine Glioma (DIPG) is co-ordinated and provided by Children’s Cancer Principal Treatment Centres (PTCs) working in conjunction with Paediatric Oncology Shared Care Units. Children’s Cancer PTCs are responsible for planning and delivering treatment for children with DIPG as well as ensuring these children can access wider support services such as psychology services, specialist play services and other therapies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:25:19 answering member 4455 label Biography information for Seema Kennedy
tabling member	4571 label Biography information for Gill Furniss

1127334

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Isotretinoin: Side Effects
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential health risks and psychiatric side-effects of the drug Roaccutane.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	255661
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>As with all medicines in the United Kingdom, the Medicines and Healthcare products Regulatory Agency continuously monitors the safety of isotretinoin-containing medicines. This includes reports of suspected adverse drug reactions submitted by healthcare professionals, patients and carers through the Yellow Card scheme, as well as published and unpublished data. As new evidence on safety emerges it is carefully evaluated and, where appropriate, product information is updated and advice for prescribers and patients is issued.</p><p>Specific assessments of possible psychiatric side effects associated with isotretinoin were considered by an Expert Working Group of the Commission on Human Medicines in 2005 and 2014. In addition, the risk of neuropsychiatric disorders was evaluated in a European review which was completed in 2018. This review concluded that the warnings in the product information for medicines containing isotretinoin regarding possible psychiatric adverse effects reflected what was known.</p><p>Since 1998, warnings regarding the possible risk of developing depression and other psychiatric side effects have been included in the product information for Roaccutane and the generic versions of isotretinoin (the Summary of Product Characteristics for healthcare professionals and the patient information leaflet). The product information for isotretinoin warns that treatment may be associated with possible psychiatric side effects, that particular care needs to be taken in patients with a history of depression; and that all patients on isotretinoin should be monitored for signs of depression and referred for appropriate treatment if necessary. It also states that stopping isotretinoin may not lead to improvement and therefore further psychiatric or psychological evaluation may be necessary.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/05/2019 16:42:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly